. "3 Molybdenum-99/Technetium-99m Supply." Medical Isotope Production Without Highly Enriched Uranium. Washington, DC: The National Academies Press, 2009.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Medical Isotope Production without Highly Enriched Uranium
TABLE 3.1 Principal Large-Scale and Regional Producers of Mo-99
NOTE: Percentages are estimates and vary depending on global reactor production schedules.
aThese percentages include production of Mo-99 by ANSTO. However, ANSTO shut down its production in January 2007 and has been purchasing Mo-99 while it converts its processing facilities to use the CNEA-developed LEU-based Mo-99 production process.
SOURCE: Supply quantities from Bonet et al. (2005).
FIGURE 3.1 Large-scale global production of Mo-99 and supply to the U.S. market.
NOTE: Arrows indicate only the major flows of Mo-99. There are secondary flows among producers that are not shown on the figure.
